We need fearless science now more than ever. That’s where you come in. Your Obliteride dollars support research to help stop cancer and infectious diseases and save lives. Thanks to our generous sponsors, every participant-raised dollar fuels Hutch scientists working on the front lines to create a healthier world for everyone.
Because the COVID-19 pandemic continues to pose an urgent threat, particularly for people affected by cancer, 50% of the funds Obliteriders raised in 2020 are supporting critical coronavirus research at Fred Hutch and 50% support our core goal: curing cancer faster. In 2021, all participant-raised dollars will fuel cancer research. See some of the passionate researchers, and work, you make possible:
As a gastroenterologist and clinical researcher, Dr. Issaka is working to decrease the number of people who die from colorectal cancer, especially in communities that have unjust and unequal access to medical care. “Screening is a way to not only prevent disease but reduce racial and economic disparities,” says Dr. Issaka. “We need to close that gap so that every citizen can benefit from … advances in cancer care and prevention.” Because colorectal cancer is one of the fastest-rising cancers in the U.S. — and because early detection can improve outcomes — Dr. Issaka’s work has the potential to save countless lives.
Dr. Pergam is an infectious disease researcher at Fred Hutch and medical director of infection prevention at Seattle Cancer Care Alliance (SCCA). Since the first days of the pandemic, Dr. Pergam has applied his expertise, clarity, and compassion to lead the infection control and response strategy at SCCA and Fred Hutch. Dubbed the “Miss Manners of Social Distancing” by The Seattle Times, he has also provided critical support to policymakers and the general public — helping to protect patients, caregivers, and our communities.
Dr. Betz Halloran is a global expert in using statistics and dynamic models to understand infectious disease outbreaks and to evaluate vaccines and vaccination strategies. Her work is used to develop strategies to stop outbreaks of global threats such as Zika virus disease, Ebola virus disease, influenza, cholera and dengue fever. Most recently, she has been advising the World Health Organization and is part of a team modeling the anticipated spread of COVID-19 for the White House.
Dr. Mueller is working to understand what causes cancers that affect women and children — and how to prevent them. As a cancer and reproductive health epidemiologist, she studies the roles of maternal, gestational, and early environmental exposures on the occurrence of childhood cancer, autoimmune diseases, fetal death, low birth weight, and preterm delivery. She’s also shining a light on the impact of reproductive history in relation to cancer, and cancer survival, among women.
Dr. Michael Boeckh
Preventing infectious disease in vulnerable patients
Dr. Melody Campbell
Unlocking how cells work and grow
Dr. Eric Chow
Improving health after cancer
Dr. Cyrus Ghajar
Understanding tumor metastasis
Dr. Gavin Ha
Harnessing data and DNA to stop cancer
Dr. Elizabeth Halloran
Global leader in infectious disease and vaccine research
Dr. Rachel Issaka
Improving colorectal screening
Dr. Holly Janes
Biostatistics to improve vaccine studies, disease treatment, and prevention
Dr. Stephanie Lee
Improving the lives of transplant recipients
Dr. Catherine Liu
Preventing infection in vulnerable patients
Dr. Julie McElrath
Global leader in infectious disease and vaccine research
Dr. Jason Mendoza
Tackling inequities in health care
Dr. Beth Mueller
Understanding cancer risk for women and children
Dr. Steve Pergam
Protecting patients from disease
Dr. Joshua Schiffer
New approaches to HIV, HSV, and COVID-19
Have fun and help cure cancer faster. Ready for another great year? Sign up to be notified when Obliteride 2021 registration opens.